Search Results
Showing 50 out of 156 results for-
October 2024: Stool Testing Universal Laboratory (STUL) Kit for Microbiology
-
September 2024: Test Update – Vasoactive Intestinal Polypeptide (VIP), Plasma
-
Sept 2024: Immediate Test Change – Testosterone, Free and Total
Beginning September 12, 2024, Testosterone, Free and Total (TFTEST) will be sent to a different reference laboratory due to reagent problems.
-
July 2024: Blood Culture Bottle Shortage
-
Register Now! 2025 Cleveland Clinic Multispecialty Pathology Symposium
-
June 2024: Test Update – Vasoactive Intestinal Polypeptide (VIP), Plasma
-
Test Discontinuation: Creatine Kinase-Myocardial Band
CKMB is an antiquated cardiac marker due to its limited clinical utility. Current guidelines recommend cardiac troponin testing.
-
New Test: Alzheimer’s Disease Biomarker Panel, Cerebrospinal Fluid
This test measures p-Tau181, Total-Tau, and β-Amyloid in cerebrospinal fluid (CSF) from adult patients 55 years of age and older.
-
January 2024: Send-Out Test Delays Caused by Weather
-
November 2023: Product Discontinuation – BD CultureSwab™
The eSwab™ (Copan Diagnostics) collection device—utilized by Cleveland Clinic for 8+ years—will now be the primary swab for bacteriology.
-
November 2023: Test Update – Chromogranin A, New Assay
-
November 2023: Test Delay – Oxalate, Plasma and Oxalate, 24-hour Urine
-
2024 Cleveland Clinic Laboratories Soft Tissue Pathology Course – Registration Now Open
This four-day course is a one-of-a-kind experience in one of the country’s busiest soft tissue pathology consultation practices.
-
September 2023: Changes to Reference Ranges – Catecholamines, Fractionated, Plasma (PLCAT)
Changes are effective October 2, 2023. For more information, please contact Client Services for assistance.
-
August 2023: Test Discontinuation – HIV-1 Western Blot (HIV1CO)
As an alternative, Cleveland Clinic Laboratories recommends HIV-1 p24 Ag + HIV-1-2 Ab, with reflex to differentiation (HIV12C) testing.
-
July 2023: Updates to COMAP, DRGTOF, MECDRG, TAPENU, and UASFR
All changes are effective August 21, 2023. For more information, please contact Client Services for assistance.
-
July 2023: Updates to Genital & Sexual Health Specimen Collection
-
July 2023: Updates to Recommended Myelodysplastic Syndrome Testing
In keeping with the NCCN guidelines, Chromosome Analysis with Reflex to FISH (CHRMDS) is the recommended test for MDS.
-
Cleveland Clinic and LabConnect Announce Strategic Alliance
This new strategic alliance will accelerate clinical trials and connect patients to new medicines for improved patient care.
-
CC-SIGN Targeted Oncology Panel by Next-Generation Sequencing
-
CC-SIGN® Targeted Oncology Panel (TOP) by Next-Generation Sequencing
This custom 59-gene NGS panel identifies SNVs, indels, CNVs from DNA, and fusion transcripts, and aberrant transcripts from RNA.
-
May 2023: Discontinued – Natural Killer Cells, Functional (NKFUNC)
-
May 2023: New Test – Clozapine (CLOZA)
-
May 2023: COVID-19 Testing – CPT Code Update
-
May 2023: Changes to Legionella Diagnostic Testing (LEGPCR)
-
April 2023: Updates to H. pylori Urea Breath Test
-
2024 Cleveland Clinic Multispecialty Pathology Symposium – Register Now!
Join us for the 2024 Cleveland Clinic Multispecialty Pathology Symposium, January 26-28, 2024, at the Wynn Las Vegas.
-
February 2023: Send-out Test Discontinuation – T3 Uptake (T3U)
Changes are effective February 21, 2023. If you have any questions about these changes, please contact Client Services for assistance.
-
December 2022: Changes to Acceptable Tube Type for Azole Anti-Fungal Therapeutic Drug Monitoring
All changes are effective December 20, 2022. If you have any questions about these changes, please contact Client Services for assistance.
-
Pathology Insights: Tumors of the Lung with Sanjay Mukhopadhyay, MD
In this video, Sanjay Mukhopadhyay, MD, briefly covers all lung tumor types listed in the new (2021) World Health Organization classification.
-
August 2022: Changes to C Telopeptide, Beta Cross Linked (CTELO)
Changes are effective as of September 6, 2022. For more information, please contact Client Services for assistance.
-
September 2022: Best Practice for Detecting Hyperhomocysteinemia – Homocysteine Testing—Not MTHFR Genotyping
If there is a clinical concern regarding hyperhomocysteinemia, CCL recommends Homocysteine testing (HOMCYS) in place of MTHFR genotyping.
-
Pathology Insights: Update on Small Round Cell Tumors with Scott Kilpatrick, MD
In this video, Dr. Kilpatrick provides context and WHO updates on the evolving classification of undifferentiated round cell sarcomas.
-
July 2022: Test Delay – Testosterone, Total and Free, Serum (TFTEST)
Effective July 18, 2022, Testosterone, Total and Free, Serum (TFTEST) testing is currently delayed for approximately three weeks.
-
July 2022: Changes to Sulfonylurea Hypoglycemics (SULFON)
Changes are effective as of July 5, 2022. For more information, please contact Client Services for assistance.
-
June 2022: Changes to Testosterone, Total and Free, Serum (TFTEST)
Changes are effective as of June 30, 2022. For more information, please contact Client Services for assistance.
-
May 2022: Immediate Test Discontinuation – Giardia lamblia IgG, IgA, IgM (GIAGAM)
Giardia lamblia IgG, IgA, IgM (GIAGAM) testing has been discontinued by the performing reference laboratory effective May 16, 2022.
-
May 2022: Test Discontinuation – Legionella Testing, LEGMAB & SLEGAB
LEGMAB and SLEGAB will be discontinued effective May 2, 2022. For more information, please contact Client Services for assistance.
-
Test Delay: Alpha 1 Antitrypsin Phenotype (A1APHE)
Test delay announcement effective April 14, 2022. For more information, please contact Client Services for assistance.
-
April 2022: Changes to CTELO, MECDS9, and K2 Testing
All changes are effective May 16, 2022. For more information, please contact Client Services for assistance.
-
March 2022: Changes to CBCDIF Result Reporting; Aldosterone Reference Intervals
Several changes impacting CBCDIF, ALDO, RENIND, and ALDREN testing are effective as of February 28, 2022. Read more for details.
-
February 2022: Immediate Test Discontinuation – Digoxin, Free, Serum (DIGFR)
Due to supply issues, Digoxin, Free, Serum (DIGFR) testing is temporarily discontinued effective February 28, 2022.
-
Estimated Glomerular Filtration Rate (eGFR) Updates
Recently released recommendations affecting a race variable in eGFR reporting have resulted in changes at Cleveland Clinic.
-
February 2022: Changes to Mycoplasma genitalium (MYGPCR)
Any additional information will be included in a future Technical Update. If you have any questions, please contact Client Services.
-
February 2022: Epic Beaker LIS Go-Live at Cleveland Clinic
On Saturday, February 26, 2022, Cleveland Clinic Laboratories will transition to the Epic Beaker laboratory information system (LIS).
-
January 2022: Changes to Specimen Requirements, Reference Ranges, and More
All changes are effective February 22, 2022. For more information, please contact Client Services for assistance.
-
December 2021: Test Delay – HIV-1 Antibody Confirmation by Western Blot (HIV1CO)
HIV-1 by Western Blot (HIV1CO) testing is experiencing extended test delays caused by a nationwide shortage of testing kits.
-
October 2021: Limited Availability of Amies Dual Swabs, ESwabs™
Intermittent supply chain interruptions are anticipated for Amies Dual Swabs and ESwabs™ through early 2022.
-
October 2021: TFTEST – Temporary Change in Performing Send-out Laboratory
Beginning October 25, 2021, Testosterone, Total and Free, Serum (TFTEST) will be temporarily sent to an alternate reference laboratory.
-
September 2021: New Test – Beta(β)-D-Glucan Assay
This FDA-approved assay diagnoses certain systemic fungal infections and supports anti-fungal therapy responses in hospitalized patients.